You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This book describes a diverse analysis of the five somatostatin receptors; somatostatin gene regulation; promatostatin processing; mechanisms of signal transduction; and the design and use of somatostatin analogues, including their possible clinical implications. The book will provide a comprehensive summary of the cellular and molecular biology of somatostatin and its recently isolated receptors. The book will review the design and use of specific somatostatin analogues both biochemically to characterize the specific functions of somatostatin and clinically in the treatment of various tumors.
Since the pioneering publications on coordination chemistry by Lehn and Pedersen in the late 1960s, coupled with the more orthodox interest from the transition metal chemists on template reactions (Busch, 1964), the field of supramolecular chemistry has grown at an astonishing rate. The use of transition metals as essential constituents of multi-component assemblies has been especially sharp in recent years, since the metals are prone to quick and reversible redox changes, and there is a wide variety of metal--ligand interactions. Such properties make supramolecular complexes of transition metal ions suitable candidates for exploration as light--energy converters and signal processors. Transition Metals in Supramolecular Chemistry focuses on the following main topics: (1) metal controlled organization of novel molecular assemblies and shapes; (2) design of molecular switches and devices operating through metal centres; (3) supramolecular catalysts that mimic metalloenzymes; (4) metal-containing sensory reagents and supramolecular recognition; and (5) molecular materials that display powerful electronic, optoelectronic and magnetic properties.
The manuscripts in this volume were contributed by the speakers invited to the Acromegaly Centennial Symposium held in San Francisco, California in July 1986. The meeting was organized to commemorate the description of acromegaly by the French physician Pierre Marie, in 1886. The members of the Scientific Committee spent many hours assisting us in ensuring an outstanding meeting. The support of Serono Symposia, USA in all phases of the planning and execution of the meeting was sincerely appreciated and was highly professional. Special recognition roust be extended to Professor Roger Guillemin of the Salk Institute, whosp interest in medical history led him to devote a great deal of time and ...
Neuropeptides rank among the phylogenetically oldest interneuronal signal substances. In the concept of neuro-secretion they were identified as neurohormones by which - via the blood - the brain regulates peripheral functions. It is now evident that the neuropeptides act as neurotransmitters/-modulators, as (neuro-)hormones, and paracrine or autocrine signal substances in diverse parts of the body. This book reviews, in several comprehensive articles written by distinguished specialists, the state of the art in the field of neuropeptides and peptidergic neurons. Special topics concern molecular aspects of processing, release and degradation of neuropeptides, receptors and signal transduction, comparative and behavioural aspects, and immunoregulatory effects of neuropeptides and their involvement on pathology of the central nervous system.
Nuclear Oncology describes the use of radionuclides in the diagnosis and management of malignant tumors. Both in vivo and in vitro techniques are included. The book was written by an international panel of authors, most, if not all, of whom are the pioneers of the techniques described. Their chapters reflect the universal views in the field of nuclear medicine and oncology. Clinical aspects and technical details are presented for both standard and new nuclear oncological techniques, including breast scintigraphy, receptor imaging, monoclonal antibodies and positron emission tomography. This information will therefore be helpful to those dealing with the diagnosis and therapy of cancer using radionuclides, including medical oncologists, radiation oncologists, oncologic surgeons, nuclear medicine physicians and radiologists. Attention is devoted to potential areas of clinical research in nuclear oncology. Therapeutic use of radionuclides is emphasized.
Pharmacochemistry Library, Volume 19: Small Peptides: Chemistry, Biology, and Clinical Studies focuses on the processes, reactions, properties, and characteristics of peptides, including analogues and proteases. The publication first takes a look at angiotensin II and bombesin/gastrin-releasing peptide. Topics include conformationally restricted analogues of bombesin, non-peptide antagonists of angiotensin II, receptor subtypes of angiotensin II, and bombesin/GRP antagonists and cancer. The text then elaborates on bradykinin, cholecystokinin, and enkephalin analogues. The manuscript examines luteinizing hormone releasing hormone and somatostatin. Topics include enzymic degradation of somatostatin and analogues, clinical applications of somatostatin analogues, and pharmacological and clinical studies with LHRH agonists and antagonists. The formulation of peptides and inhibitors of aspartyl proteases are also mentioned. The book is a valuable source of information for chemists, biologists, and readers interested in small peptides.
Recent advances in technology have greatly impacted upon the practice of nuclear medicine in general, and the approach to hepatobiliary diseases in particular. Empha sis is now placed more on non-invasive functional imaging with quantification, a feature unique to nuclear medicine and not available from any other competing diag nostic imaging modality. By providing a measure of severity of disease, quantification aids not only in timing of therapy but also for testing whether or not the chosen therapy has achieved the intended goals and objectives. This is the first textbook of its kind in the new millennium on nuclear hepatology to fully integrate quantitative physiology with morphology in the diagnosis of hepatobiliary diseases. The conception of nuclear hepatology occurred in the late 1940s with the introduc tion of radiocolloids, whose rate of clearance from blood was used as a measure of hepatic blood flow. Radiocolloid imaging of the liver, introduced first in the mid 1950s, was the most popular nuclear medicine imaging procedure in the 1970s and early 1980s, accounting for nearly 50% of the total workload in many nuclear medicine departments.
Describes the ability of a series of endocrine-derived compounds, i.e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to exert a direct anti-neoplastic activity or to potentiate the activity of traditional chemotherapeutic agents on neuroendocrine and solid tumors. In addition, a new class of potent GH-releasers, GSHs/Ghrelin, endowed with important endocrine and extra-endcocrine action, is presented. Therefore, in addition to traditional chemotherapy, characterized by high toxicity and non-selective action on tumoral cells, the reader can find a new approach with more selective, less cytotoxic endocrine derived compounds.
Update on basic and clinical research on pituitary function and disease.